Patent details

Basic Information

Publication number:

EP2214666

PCT Application Number:

PCT/US/2008/078786

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP088362561

PCT Publication Number:

WO/2009/046323

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METHOD FOR REDUCING AMYLOID DEPOSITION, AMYLOID NEUROTOXICITY, AND MICROGLIOSIS WITH (-)-NILVADIPINE ENANTIOMER

French Title of Invention:

PROCÉDÉ DE RÉDUCTION DU DÉPÔT AMYLOÏDE, DE LA NEUROTOXICITÉ AMYLOÏDE ET DE LA MICROGLIOSE AVEC L'ÉNANTIOMÈRE (-)-NILVADIPINE

German Title of Invention:

VERFAHREN ZUR REDUZIERUNG DER AMYLOID-ABSCHEIDUNG, AMYLOID-NEUROTOXIZITÄT UND MIKROGLIOSE MIT (-)-NILVADIPIN-ENANTIOMER

SPC Number:

Dates

Filing date:

03/10/2008

Grant date:

11/12/2013

EP Publication Date:

11/12/2013

PCT Publication Date:

09/04/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

11/08/2010

EP B1 Publication Date:

11/12/2013

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

03/10/2014

Expiration date:

03/10/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

03/10/2008

 

 

Name:

Alzheimer's Institute of America Inc.

Address:

7837 Parallel Parkway, Kansas City, KS 66112, United States (US)

Inventor

1

Name:

IVEY Robert, A., III

Address:

United States (US)

2

Name:

PARIS Daniel

Address:

United States (US)

3

Name:

MULLAN Michael, J.

Address:

United States (US)

Priority

1

Priority Number:

977953 P

Priority Date:

05/10/2007

Priority Country:

United States (US)

2

Priority Number:

46109

Priority Date:

18/04/2008

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/4422;

Filing date	Document type	Number of pages